Furthermore, it has been proposed in the recent literature that higher baseline levels of the so-called soluble ST2 (suppressor of tumorigenicity 2), a marker of myocardial fibrosis and remodeling, are associated with a higher risk of death and or re-hospitalization in HF. This evidence concerns the gene IL1RL1 and hydrops fetalis.